Live Breaking News & Updates on Sole Contact

Stay updated with breaking news from Sole contact. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

TurnSole Biologics: TurnSole Announces Regulatory Authority Approval and Subsequent Initiation of a Phase Ib/II Trial to evaluate the efficacy and the safety of TS-020 in acute COVID-19 viral infection in Patients with Severe Infection with Risk of Progre


(1)
PÉCS, Hungary and BUDAPEST, Hungary, March 04, 2021 (GLOBE NEWSWIRE) TurnSole Biologics (TurnSole) today announced the start of a Phase I/II open-label study for Azacytidine, initiated with a lead-in dose escalation pharmacokinetic Phase I/b part in the 20-50 mg/m2 range to evaluate safety in Hospitalized COVID-19 Patients in Severe Infection with Risk of Progression as Add-on Therapy to Standard of Care, continued with a Randomized, Controlled, Open-Label Adaptive Phase II part to Determine Efficacy and Safety.
Coronavirus disease 2019 (COVID-19) is defined as illness caused by a novel coronavirus now called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; formerly called 2019-nCoV), which was first identified amid an outbreak of respiratory illness cases in Wuhan City, Hubei Province, China. Severe illness can occur in otherwise healthy individuals of any age, but it predominantly occurs in adults with advanced age or underlying medical comorbidities ....

Gabor Heltovics , Kostenloser Wertpapierhandel , Tibor Rauch , Sole Biologics , Severe Infection , Add On Therapy , Open Label Adaptive Phase , Determine Efficacy , Wuhan City , Hubei Province , South Pest Central Hospital , Sole Contact , Co Vid , திபோர் ரௌச் , ஒரே உயிரியல் , கடுமையானது தொற்று , திறந்த லேபிள் மாற்றி அமைக்கத்தக்க கட்டம் , தெற்கு பூச்சி மைய மருத்துவமனை , ஒரே தொடர்பு , இணை வித் ,